cefazolina normon stungulyfsstofn og leysir, lausn í bláæð 1 g
laboratorios normon, s.a. - cefazolinum natríum - stungulyfsstofn og leysir, lausn - í bláæð 1 g
kefzol stungulyfs-/innrennslisstofn, lausn 1 g
stada nordic aps. - cefazolinum natríum - stungulyfs-/innrennslisstofn, lausn - 1 g
nordimet
nordic group b.v. - stendur - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - Æxlishemjandi lyf - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
fenylefrin abcur stungulyf, lausn 0,05 mg/ml
abcur ab - phenylephrinum hýdróklóríð - stungulyf, lausn - 0,05 mg/ml
fenylefrin abcur stungulyf, lausn 0,1 mg/ml
abcur ab - phenylephrinum hýdróklóríð - stungulyf, lausn - 0,1 mg/ml
aerinaze
n.v. organon - desloratadine, pseudophedrine sulfate - rinitis, ofnæmi, árstíðabundin - nasal undirbúningur - einkennameðferð við árstíðabundinni ofnæmiskvef í tengslum við nefstífla.
biorphen stungulyf, lausn 10 mg/ml
sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf, lausn - 10 mg/ml
biorphen stungulyf/innrennslislyf, lausn 0,1 mg/ml
sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf/innrennslislyf, lausn - 0,1 mg/ml